Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter, Phase 1/1b, Open Label Study Evaluating the Safety, Tolerability and Pharmacokinetics of Rilotumumab in Japanese Subjects

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01791374
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:59.044743+00:00
Published At
2016-02-29T00:00:00+00:00
Record Updated At
2016-02-29
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Part 1- Advanced Solid Tumors", "Part 2- Advanced or Metastatic Gastric Cancer", "Part 2- Advanced or Metastatic GEJ"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-02-29"
protocolSection.identificationModule.nctId
"NCT01791374"
protocolSection.identificationModule.officialTitle
"A Multicenter, Phase 1/1b, Open Label Study Evaluating the Safety, Tolerability and Pharmacokinetics of Rilotumumab in Japanese Subjects"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Part 1- Advanced Solid Tumors (protocolSection.conditionsModule.conditions)
  • Part 2- Advanced or Metastatic Gastric Cancer (protocolSection.conditionsModule.conditions)
  • Part 2- Advanced or Metastatic GEJ (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.